These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5815224)

  • 1. Prazepam in the treatment of spasticity. A quantitative double-blind evaluation.
    Levine IM; Jossmann PB; Friend DG; DeAngelis V
    Neurology; 1969 May; 19(5):510-6. PubMed ID: 5815224
    [No Abstract]   [Full Text] [Related]  

  • 2. Diazepam in the treatment of spasticity. A preliminary quantitative evaluation.
    Evine IM; Jossmann PB; Friend DG; DeAngelis V; Kane M
    J Chronic Dis; 1969 Jun; 22(1):57-62. PubMed ID: 5794241
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.
    Hedley DW; Maroun JA; Espir ML
    Postgrad Med J; 1975 Sep; 51(599):615-8. PubMed ID: 1105499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lioresal (baclofen) treatment of spasticity in multiple sclerosis.
    Basmajian JV
    Am J Phys Med; 1975 Aug; 54(4):175-7. PubMed ID: 1098477
    [No Abstract]   [Full Text] [Related]  

  • 5. Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation.
    Levine IM; Jossmann PB; DeAngelis V
    Dis Nerv Syst; 1977 Dec; 38(12):1011-5. PubMed ID: 338269
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind controlled comparison of lorazepam and glutethimide as night-before-operation hypnotics.
    Powell WF; Comer WH
    Anesth Analg; 1973; 52(3):313-6. PubMed ID: 4574959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychopharmacologic profile of prazepam].
    Boissier JR; Zebrowska-Lupina I; Simon P
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):330-44. PubMed ID: 5062440
    [No Abstract]   [Full Text] [Related]  

  • 8. Subarachnoid phenol block in the treatment of pain and spasticity.
    Cain HD
    Paraplegia; 1965 Aug; 3(2):152-60. PubMed ID: 5898422
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Horne ML
    JAMA; 1976 Jan; 235(3):251. PubMed ID: 946040
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis].
    Jerusalem F
    Nervenarzt; 1968 Nov; 39(11):515-7. PubMed ID: 4884753
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safe use of nitrazepam (Mogadon) during anticoagulant treatment with phenprocoumon (Marcoumar)].
    Breed DW; Haanen C
    Ned Tijdschr Geneeskd; 1971 Oct; 115(44):1835-7. PubMed ID: 5148283
    [No Abstract]   [Full Text] [Related]  

  • 12. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
    Monster AW; Herman R; Meeks S; McHenry J
    Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Tolosa ES; Soll RW; Loewenson RB
    JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary report on the treatment of spasticity with 45 per cent ethyl alcohol injections into the muscles.
    Cockin J; Hamilton EA; Nichols PJ; Price DA
    Br J Clin Pract; 1971 Feb; 25(2):73-5. PubMed ID: 5551572
    [No Abstract]   [Full Text] [Related]  

  • 15. The quantitative evaluation of intravenous methocarbamol in the relief of spasticity.
    Levine IM; Jossmann PB; Rudd J; De Angelis V
    Neurology; 1968 Jan; 18(1 Pt 1):69-74. PubMed ID: 4865709
    [No Abstract]   [Full Text] [Related]  

  • 16. [Demonstration of the exceptional anti-epileptic properties of a new benzodiazepine using a screening technic].
    Gastaut H; Catier J; Dravet C; Roger J
    Rev Neurol (Paris); 1969 Jun; 120(6):402-7. PubMed ID: 5379319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple sclerosis. 8. Intrathecal phenol block in spasticity].
    Fagerberg G; Höök O
    Lakartidningen; 1970 Jul; 67(29):3315-7. PubMed ID: 5452191
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study.
    Basmajian JV; Yucel V
    Am J Phys Med; 1974 Oct; 53(5):223-8. PubMed ID: 4153338
    [No Abstract]   [Full Text] [Related]  

  • 19. Content analysis of speech samples to determine effect of lorazepam on anxiety.
    Gottschalk LA; Elliott HW; Bates DE; Cable CG
    Clin Pharmacol Ther; 1972; 13(3):323-8. PubMed ID: 5026373
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of the infantile lightning-nodding-salaam spasms and myoclonic-astatic spasms using Radedorm].
    Degen R; Lässker G
    Dtsch Gesundheitsw; 1969 Oct; 24(43):2042-5. PubMed ID: 5365551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.